CINCINNATI, May 12, 2008 (PRIME NEWSWIRE) -- Meridian Bioscience, Inc. (Nasdaq:VIVO) today announced that the Company has been invited to present at the NASDAQ 21st Investor Program, London on Wednesday, May 21, 2008 at 11:15 a.m. BST at The Andaz Hotel, London, UK. Bill Motto, Executive Chairman of the Board and Jack Kraeutler, Chief Executive Officer, are scheduled to present. A question and answer session will follow the Company’s presentation. The information provided during the session may not have been previously disclosed.
